W. Giles-Davis

发表

DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins

H. Deng, H. Ertl, A. Wlazlo, 2004, Cancer Gene Therapy.

Immunoinhibitory Pathway Aged Mice through Blockade of an T Cell Responses in + Virus-Specific CD8 Augmentation of Primary Influenza A

H. Ertl, Hong-gang Yu, Dongming Zhou, 2010 .

Augmentation of Primary Influenza A Virus-Specific CD8+ T Cell Responses in Aged Mice through Blockade of an Immunoinhibitory Pathway

H. Ertl, Hong-gang Yu, M. Lasaro, 2010, The Journal of Immunology.

Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice.

H. Ertl, M. Lasaro, W. Weninger, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector

S. Reddy, H. Deng, H. Ertl, 1999, Gene Therapy.

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens

M. Betts, Z. Xiang, H. Ertl, 2009, The Journal of Immunology.

Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus Vectors

N. Letvin, S. Hensley, Z. Xiang, 2007, Journal of Virology.

Induction of CD8+ T Cells to an HIV-1 Antigen through a Prime Boost Regimen with Heterologous E1-Deleted Adenoviral Vaccine Carriers 1

H. Ertl, James M. Wilson, G. Gao, 2003, The Journal of Immunology.

Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy.

G. Freeman, M. Herlyn, J. Rabinowitz, 2017, Cancer cell.

Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.

Z. Xiang, H. Ertl, Dongming Zhou, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice.

H. Ertl, Dongming Zhou, W. Xiao, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer.

Z. Xiang, H. Ertl, Dongming Zhou, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

A method that allows easy characterization of tumor-infiltrating lymphocytes.

Z. Xiang, M. Blaszczyk-Thurin, H. Ertl, 2001, Journal of immunological methods.

Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cells.

H. Ertl, D. Kowalczyk, A. Wlazlo, 2000, Journal of immunological methods.

A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag 1

Z. Xiang, H. Ertl, James M. Wilson, 2003, The Journal of Immunology.

Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.

B. Williams, R. Silverman, S. Hensley, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Dendritic Cell Maturation, but Not CD8+ T Cell Induction, Is Dependent on Type I IFN Signaling during Vaccination with Adenovirus Vectors1

S. Hensley, H. Ertl, W. Weninger, 2005, The Journal of Immunology.

Adenovirus Vectors Signaling during Vaccination with Cell Induction , Is Dependent on Type I IFN T + Dendritic Cell Maturation , but Not CD 8

S. Hensley, H. Ertl, W. Giles-Davis, 2005 .

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.

Z. Xiang, H. Ertl, M. Lasaro, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Recombinant Vaccine to HIV-1 Gag A Simian Replication-Defective Adenoviral

Z. Xiang, H. Ertl, G. Pavlakis, 2013 .

Robust genital gag‐specific CD8+ T‐cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV‐1‐gag

H. Ertl, L. Dimenna, Shih-Wen Lin, 2010, European journal of immunology.

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.

Z. Xiang, H. Ertl, D. Kowalczyk, 2000, Virology.

A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line.

M. Blaszczyk-Thurin, H. Ertl, D. Kowalczyk, 2002, Cellular immunology.

Prime-boost vaccinations with two serologically distinct chimpanzee adenovirus vectors expressing SARS-CoV-2 spike or nucleocapsid tested in a hamster COVID-19 model

Xiaoping Zhou, Z. Xiang, H. Ertl, 2022, bioRxiv.

Pre-clinical testing of two serologically distinct chimpanzee-origin adenovirus vectors expressing spike of SARS-CoV-2

Z. Xiang, H. Ertl, W. Giles-Davis, 2022, bioRxiv.

Chimpanzee-origin adenovirus vectors as vaccine carriers

H. Ertl, J. Wilson, G. Gao, 2006, Gene Therapy.

Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens1

M. Betts, Z. Xiang, H. Ertl, 2009, The Journal of Immunology.

Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques.

J. Brenchley, M. Betts, Z. Xiang, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack

H. Ertl, D. Kowalczyk, A. Wlazlo, 2003, Cancer Gene Therapy.

In situ stimulation of a T helper cell hybridoma with a cellulose-bound peptide antigen.

R. Hoffmann, L. Otvos, A. M. Pease, 2000, Journal of immunological methods.

An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector

Z. Xiang, H. Ertl, Dongming Zhou, 2010, Nature Protocols.

The fourth author's name was omitted from the article. The corrected author and affiliation lines are shown below.

M. Betts, Z. Xiang, H. Ertl, 2009 .

Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19

Xiaoping Zhou, Z. Xiang, H. Ertl, 2022, Microbes and Infection.

A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.

Z. Xiang, H. Ertl, R. Kurupati, 2016, Human gene therapy methods.

Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.

R. Marmorstein, H. Ertl, A. Clements, 2001, Hybridoma.

In situ identification of T helper cell epitopes from a cellulose-bound peptide array

L. Otvos, A. M. Pease, M. Rogers, 2002 .

Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma

W. Giles-Davis, Xiaowei Xu, Arezki Chekaoui, 2023, Molecular therapy oncolytics.